Bottaro; Donald P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bottaro; Donald P..The latest application filed is for "vascular endothelial growth factor antagonists".

Company Profile

3.16.11

Bottaro; Donald P. - Rockville MD
Bottaro; Donald P. - Kensington MD
- Kensington MD US
Bottaro; Donald P - Kensington MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Vascular endothelial growth factor antagonists Grant 11,434,268 - Bottaro , et al. September 6, 2	2022-09-06
Vascular Endothelial Growth Factor Antagonists App 20190177382 - BOTTARO; Donald P. ; et al.	2019-06-13
Vascular endothelial growth factor antagonists and methods of making Grant 10,035,833 - Bottaro , et al. July 31, 2	2018-07-31
Vascular Endothelial Growth Factor Antagonists App 20170267735 - BOTTARO; Donald P. ; et al.	2017-09-21
Methods for use of vascular endothelial growth factor antagonists Grant 9,550,818 - Bottaro , et al. January 24, 2	2017-01-24
Vascular Endothelial Growth Factor Antagonists And Methods For Their Use App 20150126446 - Bottaro; Donald P. ; et al.	2015-05-07
Compositions and methods for inhibition of hepatocyte growth factor receptor c-Met signaling Grant 8,754,081 - Bottaro , et al. June 17, 2	2014-06-17
Methods for diagnosing and monitoring the progression of cancer by measuring soluble c-Met ectodomain Grant 08617831 -	2013-12-31
Methods for diagnosing and monitoring the progression of cancer by measuring soluble c-Met ectodomain Grant 8,617,831 - Bottaro , et al. December 31, 2	2013-12-31
Compositions and methods for inhibition of hepatocyte growth factor receptor c-Met signaling Grant 8,569,360 - Bottaro , et al. October 29, 2	2013-10-29
Methods For Diagnosing And Monitoring The Progression Of Cancer App 20130029352 - Bottaro; Donald P. ; et al.	2013-01-31
Methods for diagnosing and monitoring the progression of cancer by measuring soluble c-Met ectodomain Grant 8,304,199 - Bottaro , et al. November 6, 2	2012-11-06
Methods For Diagnosing And Monitoring The Progression Of Cancer App 20110287450 - Bottaro; Donald P. ; et al.	2011-11-24
Compositions And Methods For Inhibition Of Hepatocyte Growth Factor Receptor C-met Signaling App 20110281907 - Bottaro; Donald P. ; et al.	2011-11-17
Compositions And Methods For Inhibition Of Hepatocyte Growth Factor Receptor C-met Signaling App 20110190295 - Bottaro; Donald P. ; et al.	2011-08-04
Methods for diagnosing and monitoring the progression of cancer Grant 7,964,365 - Bottaro , et al. June 21, 2	2011-06-21
Inhibition of cell motility, angiogenesis, and metastasis Grant 7,871,981 - Bottaro , et al. January 18, 2	2011-01-18
Truncated hepatocyte growth factor variant protein HGF/NK2 Grant 7,605,127 - Chan , et al. October 20, 2	2009-10-20
Methods for Diagnosing and Monitoring the Progression of Cancer App 20080286825 - Bottaro; Donald P. ; et al.	2008-11-20
Inhibition of cell motility, angiogenesis, and metastasis App 20070042966 - Bottaro; Donald P. ; et al.	2007-02-22
Inhibition of cell motility and angiogenesis by inhibitors of Grb2-SH2-domain Grant 7,132,392 - Bottaro , et al. November 7, 2	2006-11-07
Truncated hepatocyte growth factor variants App 20030124671 - Chan, Andrew M.L. ; et al.	2003-07-03
DNA encoding truncated hepatocyte growth factor variants Grant 6,566,098 - Chan , et al. May 20, 2	2003-05-20
Hepatic growth factor receptor is the MET proto-oncogene Grant 5,648,273 - Bottaro , et al. July 15, 1	1997-07-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.